Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum ; volume:15 ; number:1 ; day:28 ; month:10 ; year:2023 ; pages:1-13 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (28.10.2023), 1-13, 12.2023
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Goossens, Julie
Cervantes González, Alba
Dewit, Nele
Lidón, Laia
Fortea, Juan
Alcolea, Daniel
Lleó, Alberto
Belbin, Olivia
Vanmechelen, Eugeen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01336-0
- URN
-
urn:nbn:de:101:1-2024011608415799747171
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goossens, Julie
- Cervantes González, Alba
- Dewit, Nele
- Lidón, Laia
- Fortea, Juan
- Alcolea, Daniel
- Lleó, Alberto
- Belbin, Olivia
- Vanmechelen, Eugeen
- SpringerLink (Online service)
Ähnliche Objekte (12)
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
Transcriptomic profiling of sporadic Alzheimer’s disease patients
Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease
Importance of extracellular vesicle secretion at the blood–cerebrospinal fluid interface in the pathogenesis of Alzheimer’s disease
Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1A431E-associated familial Alzheimer's disease
Erratum to: Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease
CDiP technology for reverse engineering of sporadic Alzheimer’s disease
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
Transcriptomic profiling of sporadic Alzheimer’s disease patients
Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease
Importance of extracellular vesicle secretion at the blood–cerebrospinal fluid interface in the pathogenesis of Alzheimer’s disease
Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1A431E-associated familial Alzheimer's disease
Erratum to: Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease
CDiP technology for reverse engineering of sporadic Alzheimer’s disease
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
Transcriptomic profiling of sporadic Alzheimer’s disease patients
Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease
Importance of extracellular vesicle secretion at the blood–cerebrospinal fluid interface in the pathogenesis of Alzheimer’s disease
Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1A431E-associated familial Alzheimer's disease
Erratum to: Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease
CDiP technology for reverse engineering of sporadic Alzheimer’s disease
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease